Cardiac overexpression of type2 AngiotensinII receptor in transgenic mice attenuates cardiac fibrosis but not cardiac hypertrophy

被引：0
|
作者：
Kurisu, S
Sugino, H
Ozono, R
Oshima, T
Matsuura, H
Teranishi, Y
Masayuki, K
Kajiyama, G
Masaki, H
Mori, Y
Matsubara, H
机构：
[1] Hiroshima Univ, Hiroshima, Japan
[2] Kansai Med Sch, Osaka, Japan
来源：
HYPERTENSION | 1999年 / 34卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
21
引用
收藏
页码：331 / 331
页数：1
相关论文
共 50 条
  • [1] Cardiac overexpression of aldosterone-synthase induces cardiac hypertrophy in transgenic mice.
    Garnier, A
    Fuchs, S
    Morineau, G
    Cailmail, S
    Tatara, E
    Pinet, F
    Delcayre, C
    HYPERTENSION, 2000, 36 (04) : 662 - 662
  • [2] Cardiomyocyte overexpression of 11β-HSD2 leads to cardiac hypertrophy, fibrosis, and failure in transgenic mice
    Rudolph, A
    Qin, W
    Bond, BR
    Rocha, R
    McMahon, EG
    EUROPEAN HEART JOURNAL, 2003, 24 : 664 - 664
  • [3] Cardiomyocyte overexpression of 11β-HSD2 leads to cardiac hypertrophy, fibrosis, and failure in transgenic mice
    Bond, BR
    Qin, W
    Rudolph, AE
    Rocha, R
    Bloome, EA
    Goellner, JJ
    Corp, P
    Funder, JW
    McMahon, EG
    Corp, P
    CIRCULATION, 2003, 108 (17) : 153 - 153
  • [4] Reduction of Cardiac Sodium Current is Independent of Cardiac Hypertrophy in Mice with Cardiac Specific Overexpression of Type 1 Angiotensin II Receptor
    Mathieu, Sophie
    El Khoury, Nabil
    Rivard, Katy
    Nemer, Mona
    Fiset, Celine
    BIOPHYSICAL JOURNAL, 2014, 106 (02) : 327A - 327A
  • [5] Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis
    Wu, Mei-ping
    Zhang, Yi-shuai
    Xu, Xiangbin
    Zhou, Qian
    Li, Jian-Dong
    Yan, Chen
    CARDIOVASCULAR DRUGS AND THERAPY, 2017, 31 (02) : 157 - 166
  • [6] Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis
    Mei-ping Wu
    Yi-shuai Zhang
    Xiangbin Xu
    Qian Zhou
    Jian-Dong Li
    Chen Yan
    Cardiovascular Drugs and Therapy, 2017, 31 : 157 - 166
  • [7] A novel signaling mechanism of cardiac hypertrophy mediated by angiotensin II type2 receptor
    Senbonmatsu, T
    Saito, T
    Watanabe, O
    Inagami, T
    CIRCULATION, 2003, 108 (17) : 288 - 288
  • [8] VENTRICULAR HYPERTROPHY IN TRANSGENIC MICE WITH CARDIAC SPECIFIC OVEREXPRESSION OF A WILD-TYPE OR MUTANT ALPHA(1)-ADRENERGIC RECEPTOR
    MILANO, CA
    ALLEN, LF
    DOLBER, PC
    LEFKOWITZ, RJ
    CIRCULATION, 1994, 90 (04) : 304 - 304
  • [9] Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice
    Sato, Y
    Ferguson, DG
    Sako, H
    Dorn, GW
    Kadambi, VJ
    Yatani, A
    Hoit, BD
    Walsh, RA
    Kranias, EG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (43) : 28470 - 28477
  • [10] Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy
    Li, Qiaoling
    Xie, Jun
    Wang, Bingjian
    Li, Ran
    Bai, Jian
    Ding, Liang
    Gu, Rong
    Wang, Lian
    Xu, Biao
    PLOS ONE, 2016, 11 (02):
12345